Kana Sogai, DVM
About Kana Sogai, DVM
Kana Sogai, DVM, is a Medical Science Liaison at Bristol Myers Squibb in Tokyo, Japan. She has a background in veterinary medicine and previously worked as a veterinarian at Nakagawa Animal Hospital.
Current Role at Bristol Myers Squibb
Kana Sogai currently works as a Medical Science Liaison at Bristol Myers Squibb in Tokyo, Japan. In this role, she engages with healthcare professionals to facilitate scientific discussions, focusing on the hematology field. Her responsibilities cover the Kanto area, including Tokyo, Saitama, Chiba, Ibaraki, Yamanashi, and Gunma. Kana resumed this position in January 2024 after a maternity leave from July 2022 to December 2023.
Previous Experience as Veterinarian
Kana Sogai served as a veterinarian at 中川動物病院 in Tokyo from 2014 to 2018. During her tenure, she worked primarily with dogs and cats, providing medical care and treatment. Her responsibilities included diagnostic examinations, surgical procedures, and managing overall animal health. Kana's work at the clinic laid a strong foundation for her subsequent roles in the medical field.
Education and Specialized Training
Kana Sogai studied at Rakuno Gakuen University, where she earned a Bachelor of Veterinary Medicine (学士(獣医学)) after six years of study, from 2008 to 2014. During her fourth to sixth years, she specialized in veterinary pathology. Her training included conducting comprehensive tasks from autopsy to microscopic examination and diagnosis, which provided her with in-depth knowledge and hands-on experience in veterinary science.
Transition to Medical Science Liaison
In 2021, Kana Sogai joined the Japan branch of Bristol Myers Squibb as a Medical Science Liaison in the hematology field. This transition marked a shift from veterinary practice to a role focused on medical science communication and engaging with healthcare professionals. Her background in veterinary pathology and prior clinical experience as a veterinarian have contributed to her effective performance in this role, enhancing scientific discourse in the medical community.